P6-123
2006; Elsevier BV; Volume: 3; Issue: 5 Linguagem: Inglês
10.1016/j.hrthm.2006.02.1024
ISSN1556-3871
AutoresAntonio Q. Chan, Peter Chan, Estrellita Recaro Lua, R Clemente, Rosalia Cabe, Kevin J. Angelo, Xin Good, David F. Hastings,
Tópico(s)Pulmonary Hypertension Research and Treatments
ResumoObstructive sleep apnea hypopnea (OSAH) has a high prevalence in cardiac patients and adversely affects treatment outcome. OSAH induces profound changes in right ventricular (RV) function with repetitive oxidative stress to the cardiovascular (CV) system, thus increasing the risks for refractory hypertension, pulmonary hypertension, acute coronary syndrome, heart failure, stroke, malignant arrhythmias and even sudden cardiac death. This study evaluates a new method for monitoring the impact of OSAH on the CV system.
Referência(s)